PDF herunterladen
Facial Plast Surg 2009; 25(4): 260-269
DOI: 10.1055/s-0029-1242038
© Thieme Medical Publishers

Pins and Needles: Minimally Invasive Office Techniques for Facial Rejuvenation

Corey S. Maas1 , Sumit Bapna1
  • 1The Maas Clinic, San Francisco, California
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
18. November 2009 (online)

   Lizenzen und Reprints

ABSTRACT

The desire for minimally invasive facial rejuvenation has continued to increase from the perspective of both the patients and injectors. For successful rejuvenation, it is important to understand the anatomic changes of the aging face as well as the properties of available neuromodulators and soft tissue fillers. The injector should be knowledgeable of the advantages and disadvantages of each product. Patient selection, perhaps, plays the largest role in success, choosing patients that would truly benefit from and have reasonable expectations for minimally invasive techniques. Unsatisfactory outcomes can be limited by meticulous injection technique and well thought out treatment plans.

KEYWORDS

Injectables - fillers - botulinum toxin - facial rejuvenation - minimally invasive

REFERENCES

  • 1 Narins R S, Brandt F S, Lorenc Z P et al.. A randomized, multicenter study of the safety and efficacy of Dermicol-P35 and non-animal-stabilized hyaluronic acid gel for the correction of nasolabial folds.  Dermatol Surg. 2007;  33(Suppl 2) S213-S221 discussion S221
    CrossrefPubMedGoogle Scholar
  • 2 Narins R S, Brandt F S, Lorenc Z P, Maas C S, Monheit G D, Smith S R. Twelve-month persistency of a novel ribose-cross-linked collagen dermal filler.  Dermatol Surg. 2008;  34(Suppl 1) S31-S39
    CrossrefPubMedGoogle Scholar
  • 3 Eppley B L, Dadvand B. Injectable soft-tissue fillers: clinical overview.  Plast Reconstr Surg. 2006;  118 98e-106e
    CrossrefPubMedGoogle Scholar
  • 4 Reisman N R. Ethics, legal issues, and consent for fillers.  Clin Plast Surg. 2006;  33 505-510
    CrossrefPubMedGoogle Scholar
  • 5 Ali M J, Ende K, Maas C S. Perioral rejuvenation and lip augmentation.  Facial Plast Surg Clin North Am. 2007;  15 491-500
    CrossrefPubMedGoogle Scholar
  • 6 Engelman D E, Bloom B, Goldberg D J. Dermal fillers: complications and informed consent.  J Cosmet Laser Ther. 2005;  7 29-32
    CrossrefPubMedGoogle Scholar
  • 7 Maas C S, Yu K C, Egan K K. Neuromodulators and injectable soft tissue substitutes. In: Papel ID, Frodel JL, Holt GH, et al Facial Plastic and Reconstructive Surgery. 3rd ed. New York, NY; Thieme Medical Publishers 2009: 337-353
    PubMedGoogle Scholar
  • 8 Maas C S, Ende K H, Lewis D A. Soft tissue fillers. In: Truswell W Surgical Facial Rejuvenation: A Roadmap to Safe and Reliable Outcomes. New York, NY; Thieme Medical Publishers 2008: 131-138
    PubMedGoogle Scholar
  • 9 Petrus G M, Lewis D, Maas C S. Anatomic considerations for treatment with botulinum toxin.  Facial Plast Surg Clin North Am. 2007;  15 1-9, v
    CrossrefPubMedGoogle Scholar
  • 10 Maas C S. Botulinum neurotoxins and injectable fillers: minimally invasive management of the aging upper face.  Facial Plast Surg Clin North Am. 2006;  14 241-245
    CrossrefPubMedGoogle Scholar
  • 11 Ramirez A L, Reeck J, Maas C S. Botulinum toxin type B (MyoBloc) in the management of hyperkinetic facial lines.  Otolaryngol Head Neck Surg. 2002;  126 459-467
    CrossrefPubMedGoogle Scholar
  • 12 Lowe P L, Patnaik R, Lowe N J. A comparison of two botulinum type a toxin preparations for the treatment of glabellar lines: double-blind, randomized, pilot study.  Dermatol Surg. 2005;  31 1651-1654
    CrossrefPubMedGoogle Scholar
  • 13 Loos B M, Maas C S. Relevant anatomy for botulinum toxin facial rejuvenation.  Facial Plast Surg Clin North Am. 2003;  11 439-443
    CrossrefPubMedGoogle Scholar
  • 14 Stupak H D, Maas C S. New procedures in facial plastic surgery using botulinum toxin A.  Facial Plast Surg Clin North Am. 2003;  11 515-520
    CrossrefPubMedGoogle Scholar
  • 15 Dayan S H, Maas C S. Botulinum toxins for facial wrinkles: beyond glabellar lines.  Facial Plast Surg Clin North Am. 2007;  15 41-49, vi
    CrossrefPubMedGoogle Scholar
  • 16 Wise J B, Greco T. Injectable treatments for the aging face.  Facial Plast Surg. 2006;  22 140-146
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 17 Allergan, Inc. 10-k sec filing. Available at: http://sec.edgar-online.com/allergan-inc/10-k-annual-report/2007/03/01/Section3.aspx Accessed May 15, 2009
    Google Scholar
  • 18 Monheit G D. Hyaluronic acid fillers: Hylaform and Captique.  Facial Plast Surg Clin North Am. 2007;  15 77-84, vii
    CrossrefPubMedGoogle Scholar
  • 19 Brandt F S, Cazzaniga A. Hyaluronic acid fillers: Restylane and Perlane.  Facial Plast Surg Clin North Am. 2007;  15 63-76, vii
    CrossrefPubMedGoogle Scholar
  • 20 Merzpharmaceuticals. Company press release 2005. Available at: http://www.merz.com/press/press-releases/company/2005/05/12/01/ Accessed May 15, 2009
    Google Scholar
  • 21 Ahn M S. Calcium hydroxylapatite: Radiesse.  Facial Plast Surg Clin North Am. 2007;  15 85-90, vii
    CrossrefPubMedGoogle Scholar
  • 22 Narins R S, Beer K. Liquid injectable silicone: a review of its history, immunology, technical considerations, complications, and potential.  Plast Reconstr Surg. 2006;  118(3 Suppl) 77S-84S
    CrossrefPubMedGoogle Scholar
  • 23 Finn J C, Cox S. Fillers in the periorbital complex.  Facial Plast Surg Clin North Am. 2007;  15 123-132, viii
    CrossrefPubMedGoogle Scholar
  • 24 Kelly P E. Injectable success: from fillers to Botox.  Facial Plast Surg. 2007;  23 7-18 discussion 19-20
    Artikel in Thieme ConnectPubMedGoogle Scholar

Sumit BapnaM.D. 

The Maas Clinic

2400 Clay Street, San Francisco, CA 94115

eMail: drbapna@gmail.com

      >